The 12 closest competitors and alternatives to Microbion Corp — ranked by similarity to what Microbion Corp actually does, not by market-cap band.
Subscribe to see Microbion Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Microbion Corp is a clinical-stage pharmaceutical company dedicated to developing novel therapeutic solutions for serious, resistant infections. The organization focuses on building world-class capabilities to help patients in need.
Microbion Corp is a company headquartered in United States. It has raised at least $29.5M across the 2 funding rounds on record. Its most recent funding round raised $4.1M in January 2021. Xcout tracks 8 named people at Microbion Corp, including Steve Schellong (CEO).
2 more named people on record for Microbion Corp, with roles, board committees and tenure — see the full roster →
At least $29.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.1M | — | |
| SEC Form D filing | $25.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Microbion Corp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.
Close match by what they do
Melinta Therapeutics, Inc. is a U.S. pharmaceutical company focused on developing and commercializing antibiotics and other therapies for serious bacterial infections. Its products primarily serve hospitals, infectious-disease specialists, and other healthcare providers treating patients with acute or drug-resistant infections.
Biotechnology
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
Biotechnology
NanoBio Corp. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing dermatological products and anti-infective treatments.
Close match by what they do
MarvelBiome, Inc. is a clinical-stage biopharmaceutical company headquartered in Woburn, Massachusetts, focused on harnessing the power of microbes to treat human diseases.
Biotechnology
MycoRx LLC develops new antifungal drug candidates designed to overcome drug resistance and treat fungal infections ranging from recurrent skin conditions to life-threatening sepsis. The company also supports clinical trials for other drug developers and maintains safety standards in the testing and manufacturing of pharmaceutical products.
Biotech
Bugworks Research Inc. is a clinical-stage biopharmaceutical company headquartered in Bangalore, India, developing novel therapeutics to combat antimicrobial resistance.
Close match by what they do
Curza, Inc., based in Salt Lake City, Utah, is a life sciences company developing a pipeline of next-generation therapeutics. The company works to address critical global health challenges, such as the antimicrobial resistance (AMR) crisis.
Close match by what they do
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of antibody-based solutions for infectious diseases.
Biotechnology
Qpex Biopharma, Inc. is a biopharmaceutical company located in San Diego, California, specializing in infectious disease solutions as part of the Shionogi Group.
Close match by what they do
Zavante Therapeutics, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing therapies for serious infections. Its products are intended for use by hospitals and other healthcare providers treating hospitalized patients with difficult-to-treat infections.
Biotechnology
AMR Bio is a clinical-stage biotechnology company headquartered in London, United Kingdom, focused on infection prevention and antimicrobial resistance. The company is dedicated to developing novel anti-infectives, including its Phase 3-ready, first-in-class topical antimicrobial candidate XF-73.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Microbion Corpand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →